Dimitry Nuyten, M.D., Ph.D.

Dimitry Nuyten, M.D., Ph.D.

Chief Medical OfficeratArcus Biosciences· In proxies 2022–2024

Pay in FY2023-20% from the year before

Dimitry Nuyten, M.D., Ph.D. was paid $3.7M in FY2023 (Dec), down 20%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Arcus Biosciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Arcus BiosciencesPublic company · 4 yr
    • Chief Medical Officer2022 – Present · 4 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?